Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study Academic Article 2014 uri icon

authors

  • Antonella Castagna
  • Santiago Moreno
  • Manuela Doroana
  • Mounir Ait-Khaled
  • Jenny Huang
  • Sherene Min
  • Ivy Song
  • Cindy Vavro
  • Garrett Nichols
  • Jane M. Yeo
  • BOIX MARTINEZ, VICENTE
  • Franco Maggiolo
  • Giovanni Penco
  • David Wright
  • Anthony Mills
  • Robert Grossberg
  • Jean-Michel Molina
  • Julie Chas
  • Jacques Durant

publication date

  • 2014